What is US8829195, and how does it relate to asciminib?
US8829195 is a patent published in the context of inventions tied to asciminib (Scemblix). On Google Patents, it’s typically surfaced via search results around asciminib-related claims and assignee/inventor records. However, the exact claim scope and whether it directly covers asciminib itself or an adjacent formulation/targeting method depends on the specific claim language in the patent document.
How to find US8829195 on Google Patents (fast)
On Google Patents, search by:
- US8829195
- or asciminib US8829195
Then confirm you are viewing the correct record by checking:
- the publication/application number shown in the header
- the title
- the assignee/inventor fields
- the “Claims” section for any direct reference to asciminib, kinase targets (e.g., BCR-ABL1), or specific chemical structures/definitions
Who is listed as the assignee, and what does that mean for ownership?
The assignee listed on the Google Patents entry indicates who owns or is associated with the patent rights for that filing. If the assignee is a company that develops asciminib or its underlying technology, that typically means the patent may be part of the broader intellectual property portfolio supporting the drug.
Does this patent still matter commercially (exclusivity/other exclusivity vs. patents)?
Even if a patent is old (US patents often have a long lifespan), the practical impact on competition can come from:
- whether related later patents cover improvements or additional claim scope,
- whether any exclusivity (regulatory or market-based) still applies in relevant jurisdictions,
- and whether bios/chemical competitors must design around the specific claims.
For asciminib-related patent landscape research, DrugPatentWatch.com is often used to track relevant filings and timing across jurisdictions: DrugPatentWatch.com.
What to check next if you want the exact claim scope
If your goal is to understand how US8829195 may cover asciminib (or not), the most important parts to read on Google Patents are:
- independent claims (they define the legal boundary)
- definitions for any chemical structure markers or functional language
- dependent claims (they show narrower embodiments)
- the specification’s description of how the invention works
If you paste the Google Patents link or the patent title/abstract text here, I can summarize what US8829195 claims and whether it appears directly on-point for asciminib.
Sources